Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

ViiV Healthcare

- PMLiVE

GSK partners with Singapore research agency on emerging markets

Will work with A*STAR’s Institute of Chemical and Engineering to research reformulated medicines

- PMLiVE

GSK’s four-strain flu vaccine approved in Germany and UK

Will be sold as Influsplit Tetra in Germany and Fluarix Tetra in the UK

- PMLiVE

FDA delays GlaxoSmithKline’s pandemic flu vaccine

More time needed due to "administrative" issue

- PMLiVE

GSK’s Ellen Strahlman joins med tech firm BD

Will serve as the US company's chief medical officer

- PMLiVE

GSK submits albiglutide for European approval

If approved the diabetes drug will be launched as Eperzan

- PMLiVE

UK study supports earlier narcolepsy finding with GSK’s Pandemrix

Flu vaccine linked to sleeping disorder

- PMLiVE

Abbott and GSK announce job cuts in Ireland

Nearly 300 positions to go in Cork and Tipperary

- PMLiVE

GSK’s COPD drug Anoro under review in US

FDA accepts new drug application for the LAMA/LABA combination

- PMLiVE

GSK signs obesity research deal with Vanderbilt University

Follows increased push from pharma to tackle the public health challenge

EU flag

Five pharma companies begin antibiotic research programme

Sanofi, GSK and AstraZeneca among the collaborators on European projects

- PMLiVE

GSK planning restructuring in Europe as earnings fall

Includes job cuts and potential sale of Ribena/Lucozade brands

- PMLiVE

GSK signs up to AllTrials trial transparency campaign

Will publish formal clinical study reports for all of its medicines

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links